Tailoring cells for clinical needs : meeting report from the advanced therapy in healthcare symposium (October 28–29 2017, Doha, Qatar)

  • New technologies and therapies designed to facilitate development of personalized treatments are rapidly emerging in the field of biomedicine. Strikingly, the goal of personalized medicine refined the concept of therapy by developing cell-based therapies, the so-called “living drugs”. Breakthrough advancements were achieved in this regard in the fields of gene therapy, cell therapy, tissue-engineered products and advanced therapeutic techniques. The Advanced Therapies in Healthcare symposium, organized by the Clinical Research Center Department of Sidra Medicine, in Doha, Qatar (October 2017), brought together world-renowned experts from the fields of oncology, hematology, immunology, inflammation, autoimmune disorders, and stem cells to offer a comprehensive picture of the status of worldwide advanced therapies in both pre-clinical and clinical development, providing insights to the research phase, clinical data and regulatory aspects of these therapies. Highlights of the meeting are provided in this meeting report.

Download full text files

Export metadata

Metadaten
Author:Sara Deola, Bella S. Guerrouahen, Heba Sidahmed, Anjud Al‑Mohannadi, Muhammad Elnaggar, Ramaz Elsadig, Essam M. Abdelalim, Goran Petrovski, Massimo Gadina, Adrian Thrasher, Winfried S. Wels, Stephen P. Hunger, Ena Wang, Francesco M. Marincola, Cristina Maccalli, Chiara Cugno
URN:urn:nbn:de:hebis:30:3-476953
DOI:https://doi.org/10.1186/s12967-018-1652-y
ISSN:1479-5876
Pubmed Id:https://pubmed.ncbi.nlm.nih.gov/30305089
Parent Title (English):Journal of translational medicine
Publisher:BioMed Central
Place of publication:London
Document Type:Article
Language:English
Year of Completion:2018
Date of first Publication:2018/10/10
Publishing Institution:Universitätsbibliothek Johann Christian Senckenberg
Contributing Corporation:ATH Consortium
Release Date:2018/10/16
Tag:Autoimmunity; Cell therapy; Clinical trials; Gene therapy; Hematology; Oncology; Personalized medicine; Preclinical; Stem cells
Volume:16
Issue:1, Art. 276
Page Number:15
First Page:1
Last Page:15
Note:
Open Access: This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
HeBIS-PPN:439193990
Institutes:Medizin / Medizin
Angeschlossene und kooperierende Institutionen / Georg-Speyer-Haus
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Sammlungen:Universitätspublikationen
Licence (German):License LogoCreative Commons - Namensnennung 4.0